Daylight Solutions secures $5M financing round

Daylight Solutions, a manufacturer of molecular detection and imaging solutions, has successfully closed a $5 million Series B financing round.

The funding will help to ensure that the company will have the resources necessary to respond to expanding opportunities from its customer base, said Paul Larson, president and COO.

The company recently introduced a broadly tunable, mode-hop free laser source for use in high resolution spectroscopy.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.